Effects of various combinations of benzodiazepines with buprenorphine on arterial blood gases in rats

Basic and Clinical Pharmacology and Toxicology

Volumn 103, Issue 3, 2008, Pages 228-239

  Pirnay, Stéphane O ^a,b,c   Mégarbane, Bruno ^b   Borron, Stephen W ^b,d   Risède, Patricia ^b   Monier, Claire ^b   Ricordel, Ivan ^c   Baud, Frédéric J ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

^c Centre Universitaire des Saints Pères   (France)

^d Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; BROMAZEPAM; BUPRENORPHINE; CLONAZEPAM; DIAZEPAM; FLUNITRAZEPAM; MIDAZOLAM; NORDAZEPAM; OXAZEPAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL GAS; ARTICLE; BREATHING RATE; COMBINATION CHEMOTHERAPY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; MALE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATION DEPRESSION; RESPIRATORY ACIDOSIS; RESPIRATORY FAILURE; SEDATION;

ANIMALS; ARTERIES; BENZODIAZEPINES; BLOOD GAS ANALYSIS; BUPRENORPHINE; CARBON DIOXIDE; DEPRESSION, CHEMICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HYDROGEN-ION CONCENTRATION; INJECTIONS, INTRAVENOUS; MALE; NARCOTICS; OXYGEN; PARTIAL PRESSURE; PSYCHOTROPIC DRUGS; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATION;

RATTUS;

EID: 49749090754     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2008.00273.x     Document Type: Article

References (30)

1. Darke S, Zador D. Fatal heroin overdose: a review. Addiction 1996 91 : 1765 72.
2. Hall W, Darke S. Trends in opiate overdose deaths in Australia 1979-1995. Drug Alcohol Depend 1998 52 : 71 7.
3. Warner-Smith M, Darke S, Lynskey M, Hall W. Heroin overdose: causes and consequences. Addiction 2001 96 : 1113 25.
4. Darke S, Topp I, Kaye H, Hall W. Heroin use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the Illicit Drug Reporting System (IDRS). Addiction 2002 97 : 179 86.
5. Emmanuelli J, Desenclos JC. Harm reduction interventions, behaviors and associated health outcomes in France, 1996-2003. Addiction 2005 100 : 1690 700.
6. McCormick GY, White WJ, Zagon IS, Lang CM. Effects of diazepam on arterial blood gas concentrations and pH of adult rats acutely and chronically exposed to methadone. J Pharmacol Exp Ther 1984 230 : 353 9.
7. Santiago TV, Goldblatt K, Winters K, Pugliese AC, Edelman NH. Respiratory consequences of methadone: the response to added resistance to breathing. Am Rev Respir Dis 1980 122 : 623 8.
8. Megarbane B, Decleves X, Bloch V, Bardin C, Chast F, Baud FJ. Case report: quantification of methadone-induced respiratory depression using toxicokinetic/toxicodynamic relationships. Crit Care 2007 11 : R5.
9. Cowan A, Doxey J, Harry EJ. The animal pharmacology of buprenorphine, an oripavine analgesic agent. Br J Pharmacol 1977 60 : 547 54.
10. Walsh S, Preston K, Stitzer ML, Cone EJ, Bigelow GE. Clinical pharmacology of buprenorphine: ceiling effect at high doses. Clin Pharmacol Ther 1994 65 : 569 80.
11. Nielsen S, Taylor DA. The effect of buprenorphine and benzodiazepines on respiration in the rat. Drug Alcohol Depend 2005 79 : 95 101.
12. Dahan A, Yassen A, Bijl H, Romberg R, Sarton E, Teppema L et al. Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats. Br J Anaesth 2005 94 : 825 34.
13. Dahan A, Yassen A, Romberg R, Sarton E, Teppema L, Olofsen E et al. Buprenorphine induces ceiling in respiratory depression but not in analgesia. Br J Anaesth 2006 96 : 627 32.
14. van Dorp E, Yassen A, Sarton E, Romberg R, Olofsen E, Teppema L et al. Naloxone reversal of buprenorphine-induced respiratory depression. Anesthesiology 2006 105 : 51 7.
15. Ohtani M, Kotaki H, Nishitateno K, Sawada Y, Iga T. Kinetics of respiratory depression in rats induced by buprenorphine and its metabolite, norbuprenorphine. J Pharmacol Exp Ther 1997 281 : 428 33.
16. Yassen A, Kan J, Olofsen E, Suidgeest E, Dahan A, Danhof M. Mechanism-based pharmacokinetic-pharmacodynamic modeling of the respiratory-depressant effect of buprenorphine and fentanyl in rats. J Pharmacol Exp Ther 2006 319 : 682 92.
17. Yassen A, Olofsen E, Romberg R, Sarton E, Teppema L, Danhof M et al. Mechanism-based PK/PD modeling of the respiratory depressant effect of buprenorphine and fentanyl in healthy volunteers. Clin Pharmacol Ther 2007 81 : 50 8.
18. Gueye PN, Borron SW, Risède P, Monier C, Buneaux F, Debray M et al. Lack of effect of single high doses of buprenorphine on arterial blood gases in the rat. Toxicol Sci 2001 62 : 148 54.
19. Gueye PN, Borron SW, Risède P, Monier C, Buneaux F, Debray M et al. Buprenorphine and midazolam act in combination to depress respiration in rats. Toxicol Sci 2002 65 : 107 114.
20. Mégarbane B, Pirnay S, Borron SW, Trout H, Monier C, Risède P et al. Flunitrazepam does not alter cerebral distribution of buprenorphine in the rat. Toxicol Lett 2005 157 : 211 9.
21. Reynaud M, Tracqui A, Petit G, Potard D, Courty P. Six deaths linked to misuse of buprenorphine-benzodiazepine combinations. Am J Psychiatry 1998 155 : 448 9.
22. Tracqui A, Kintz P, Ludes B. Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities. J Anal Toxicol 1998 22 : 430 434.
23. Kintz, P. Deaths involving buprenorphine: a compendium of French cases. Forensic Sci Int 2001 121 : 65 9.
24. Pirnay S, Borron SW, Giudicelli CP, Tourneau J, Baud FJ, Ricordel I. A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths. Addiction 2004 99 : 978 88.
25. Finkle BS, McCloskey KL, Goodman LS. Diazepam and drug associated deaths: a survey in the United States and Canada. JAMA 1979 249 : 429 34.
26. Drummer OH, Syrjanen ML, Cordner SM. Deaths involving the benzodiazepine flunitrazepam. Am J Forensic Med Pathol 1993 14 : 238 43.
27. Serfaty M, Masterton G. Fatal poisonings attributed to benzodiazepines in Britain during the 1980s. Br J Psychiatry 1993 163 : 386 93.
28. Mégarbane B, Lesguillons N, Galliot-Guilley M, Borron SW, Trout H, Declèves X, et al. Cerebral and plasma kinetics of a high dose of midazolam and correlations with its respiratory effects in rats. Toxicol Lett 2005 159 : 22 31.
29. Borron SW, Monier C, Risède P, Baud FJ. Flunitrazepam variably alters morphine, buprenorphine, and methadone lethality in the rat. Hum Exp Toxicol 2002 21 : 599 605.
30. Randall LO, Kappell B. Pharmacological activity of some benzodiazepines and their metabolites. In : Garattini S, Randall LO Mussini E (eds). The Benzodiazepines. Raven Press, New York, 1973 27 51.